1. Concern about kidney injury linked to contaminated syrup- and liquid-based medicines in children

   News item 05 November 2022 Pages: 1 - 1

2. EMA recommendations for reducing risk of serious JAK inhibitor AEs

   News item 05 November 2022 Pages: 2 - 2

3. EMA recommends market withdrawal of amfepramone for safety reasons

   News item 05 November 2022 Pages: 3 - 3

4. Iodinated contrast media-related hypothyroidism in neonates and infants

   News item 05 November 2022 Pages: 4 - 4

5. No pregnancy complications after use of mRNA COVID-19 vaccines

   News item 05 November 2022 Pages: 5 - 5

6. Risk of EVUSHELD treatment failure due to antiviral resistance

   News item 05 November 2022 Pages: 6 - 6

7. Baricitinib- and tofacitinib-related risk of VTE and cardiovascular events

   Clinical study 05 November 2022 Pages: 7 - 7

8. Immune checkpoint inhibitor-related acute kidney injury

   Clinical study 05 November 2022 Pages: 8 - 8

9. Insufficient compliance with valproate prescribing conditions in France

   Clinical study 05 November 2022 Pages: 9 - 9

10. Interferon-based therapy increases risk of autoimmune thyroid diseases

    Clinical study 05 November 2022 Pages: 10 - 10

11. Risks of thrombosis and thromboembolic events after first COVID-19 vaccination

    Clinical study 05 November 2022 Pages: 11 - 11

12. SGLT2i use increases risk of postoperative diabetic ketoacidosis

    Clinical study 05 November 2022 Pages: 12 - 12

13. Voriconazole-related hepatotoxicity in Chinese patients

    Clinical study 05 November 2022 Pages: 13 - 13

14. Other adverse reaction research

    News item 05 November 2022 Pages: 14 - 14

15. Abemaciclib/palbociclib

    Case report 05 November 2022 Pages: 15 - 15

16. Acarbose/metformin/repaglinide

    Case report 05 November 2022 Pages: 16 - 16

17. Acenocoumarol/amoxicillin/clavulanic acid

    Case report 05 November 2022 Pages: 17 - 17

18. Acenocoumarol/aspirin/clopidogrel

    Case report 05 November 2022 Pages: 18 - 18

19. Acetazolamide

    Case report 05 November 2022 Pages: 19 - 19

20. Acetylcysteine

    Case report 05 November 2022 Pages: 20 - 20

21. Aciclovir/polymixin-b/vitamins

    Case report 05 November 2022 Pages: 21 - 21

22. Acitretin

    Case report 05 November 2022 Pages: 22 - 22

23. Ad26.cov2-s

    Case report 05 November 2022 Pages: 23 - 23

24. Adalimumab

    Case report 05 November 2022 Pages: 24 - 24

25. Adalimumab/antituberculars/secukinumab

    Case report 05 November 2022 Pages: 25 - 25

26. Adefovir-dipivoxil

    Case report 05 November 2022 Pages: 26 - 26

27. Alectinib/carboplatin/paclitaxel

    Case report 05 November 2022 Pages: 27 - 27

28. Alendronic acid

    Case report 05 November 2022 Pages: 28 - 28

29. Alendronic-acid/chlorhexidine

    Case report 05 November 2022 Pages: 29 - 29

30. Alendronic-acid/levothyroxine-sodium

    Case report 05 November 2022 Pages: 30 - 30

31. Alendronic-acid/levothyroxine-sodium/risedronic-acid

    Case report 05 November 2022 Pages: 31 - 31

32. Alprazolam/mirtazapine/paroxetine

    Case report 05 November 2022 Pages: 32 - 32

33. Alprazolam/sodium valproate

    Case report 05 November 2022 Pages: 33 - 33

34. Alteplase/dalteparin sodium

    Case report 05 November 2022 Pages: 34 - 34

35. Amikacin/cotrimoxazole/imipenem

    Case report 05 November 2022 Pages: 35 - 35

36. Amisulpride/haloperidol

    Case report 05 November 2022 Pages: 36 - 36

37. Amlodipine

    Case report 05 November 2022 Pages: 37 - 37

38. Amlodipine

    Case report 05 November 2022 Pages: 38 - 38

39. Amoxicillin/clavulanic-acid/bicarbonate/ceftriaxone

    Case report 05 November 2022 Pages: 39 - 39

40. Amphotericin-b

    Case report 05 November 2022 Pages: 40 - 40

41. Amphotericin-B-liposomal/posaconazole

    Case report 05 November 2022 Pages: 41 - 41

42. Amphotericin-B/immunosuppressant

    Case report 05 November 2022 Pages: 42 - 42

43. Ampicillin/cefotaxime/mannitol

    Case report 05 November 2022 Pages: 43 - 43

44. Amygdalin overdose and misuse

    Case report 05 November 2022 Pages: 44 - 44

45. Anakinra/cotrimoxazole/prednisolone

    Case report 05 November 2022 Pages: 45 - 45

46. Anthracyclines/trastuzumab

    Case report 05 November 2022 Pages: 46 - 46

47. Antiarrhythmics

    Case report 05 November 2022 Pages: 47 - 47

48. Antibacterials

    Case report 05 November 2022 Pages: 48 - 48

49. Antibacterials

    Case report 05 November 2022 Pages: 49 - 49

50. Antibacterials

    Case report 05 November 2022 Pages: 50 - 50